Get started
Author

Saskia Bresch

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
2023 · James F Howard, Saskia Bresch, et al. · The Lancet Neurology · 282
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
2021 · Christine Lebrun-Frénay, Fabien Rollot, et al. · JAMA Network Open · 89
PDF
Immunoglobulin G4-related hypertrophic pachymeningitis
2019 · Michaël Levraut, Mikaël Cohen, et al. · Neurology Neuroimmunology & Neuroinflammation · 68
PDF
Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability
2021 · Mikael Cohen, Saskia Bresch, et al. · Multiple Sclerosis and Related Disorders · 56
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
2023 · Michael Levraut, Antoine Gavoille, et al. · Neurology Neuroimmunology & Neuroinflammation · 49
PDF
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
2024 · James F. Howard, Saskia Bresch, et al. · Therapeutic Advances in Neurological Disorders · 48
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis
2016 · Christine Lebrun, Véronique Bourg, et al. · Journal of Neuroimmunology · 47
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
2018 · Christine Lebrun, Mikael Cohen, et al. · Neurology and Therapy · 43
PDF
Cerebral Amyloid Angiopathy–Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS
2024 · Lou Grangeon, Grégoire Boulouis, et al. · Neurology · 30
Brain Natriuretic Peptide: A Relevant Marker to Rule Out Delayed Atrial Fibrillation in Stroke Patient
2012 · Laurent Suissa, Saskia Bresch, et al. · Journal of Stroke and Cerebrovascular Diseases · 29
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis
2021 · Caroline Ruetsch-Chelli, Saskia Bresch, et al. · Neurotherapeutics · 28
PDF
Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy
2019 · F. Jomier, V. Bousson, et al. · European Journal of Neurology · 24
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
2019 · C. Lebrun, S. Vukusic, et al. · Revue Neurologique · 21
Apport de l’électromyogramme dans le diagnostic précoce des SLA à début bulbaire : comparaison des critères d’El Escorial, d’El Escorial modifiés et d’Awaji
2013 · S. Bresch, E. Delmont, et al. · Revue Neurologique · 18
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
2020 · C. Donzé, C. Donzé, et al. · Revue Neurologique · 16
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
2022 · Michael Levraut, Cassandre Landes, et al. · Frontiers in Immunology · 14
PDF
Comparison of patients with biopsy positive and negative primary angiitis of the central nervous system
2023 · Ahmad Nehme, Caroline Arquizan, et al. · Lara D. Veeken · 11
PDF
Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study
2022 · Mikael Cohen, Solange Hesse, et al. · Multiple Sclerosis and Related Disorders · 9
Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis
2020 · H. Joly, N. Capet, et al. · Multiple Sclerosis and Related Disorders · 7
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population
2025 · Elisabeth Maillart, Fabien Rollot, et al. · Multiple Sclerosis Journal · 6
PDF
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
2026 · Tuan Vu, Ali A Habib, et al. · The Lancet · 5
Impact of executive dysfunction on naming ability in multiple sclerosis
2019 · Héloïse Joly, Mikaël Cohen, et al. · Revue Neurologique · 5
Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis
2024 · Charlotte Héraud, Saskia Bresch, et al. · Journal of Neurology · 4
Papilledema secondary to vestibular schwannoma: An atypical case without intracranial hypertension
2021 · A. Gavotto, V. Feuillade, et al. · Neurochirurgie · 4
Digestive side-effects with teriflunomide: Thoughts on lactose
2018 · C. Lebrun, M. Bertagna, et al. · Revue Neurologique · 4
Works count: 75
Citation count: 939
H-index: 15
I10-index: 17
Year
Topic
Type